Surgical Science Sweden AB (OSTO:SUS) Cash-to-Debt : 4.11 (As of Dec. 2024)

View and export this data going back to 2017. Start your Free Trial

What is Surgical Science Sweden AB Cash-to-Debt?

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. Surgical Science Sweden AB's cash to debt ratio for the quarter that ended in Dec. 2024 was 4.11.

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. Here we can see, Surgical Science Sweden AB could pay off its debt using the cash in hand for the quarter that ended in Dec. 2024.

The historical rank and industry rank for Surgical Science Sweden AB's Cash-to-Debt or its related term are showing as below:

OSTO:SUS' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.08 Med: 21.04 Max: No Debt
Current: 4.11

During the past 10 years, Surgical Science Sweden AB's highest Cash to Debt Ratio was No Debt. The lowest was 0.08. And the median was 21.04.

OSTO:SUS's Cash-to-Debt is ranked better than
73.15% of 663 companies
in the Healthcare Providers & Services industry
Industry Median: 0.77 vs OSTO:SUS: 4.11

Surgical Science Sweden AB Cash-to-Debt Historical Data

The historical data trend for Surgical Science Sweden AB's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

Surgical Science Sweden AB Cash-to-Debt Chart

Surgical Science Sweden AB Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Cash-to-Debt

Get a 7-Day Free Trial

37.57

26.24

29.54

15.85

4.11

Surgical Science Sweden AB Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Cash-to-Debt	Get a 7-Day Free Trial															15.85	No Debt	No Debt	No Debt	4.11

Competitive Comparison of Surgical Science Sweden AB's Cash-to-Debt

For the Health Information Services subindustry, Surgical Science Sweden AB's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Surgical Science Sweden AB's Cash-to-Debt Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Surgical Science Sweden AB's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where Surgical Science Sweden AB's Cash-to-Debt falls into.

Save Embed

;

Save Embed

;

Surgical Science Sweden AB Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

Surgical Science Sweden AB's Cash to Debt Ratio for the fiscal year that ended in Dec. 2024 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	968.155	/	(0	+	235.408)
	=	4.11

Surgical Science Sweden AB's Cash to Debt Ratio for the quarter that ended in Dec. 2024 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	968.155	/	(0	+	235.408)
	=	4.11

Surgical Science Sweden AB (OSTO:SUS) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.

Surgical Science Sweden AB Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of Surgical Science Sweden AB's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Surgical Science Sweden AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Surgical Science Sweden AB (OSTO:SUS) » Definitions » Cash-to-Debt

Comparable Companies

Traded in Other Exchanges

SUSRF:USA 4P41:Germany

Address

Drakegatan 7A, Gothenburg, SWE, SE-412 50

Website

https://www.surgicalscience.com

Surgical Science Sweden AB is a supplier of virtual reality simulators for medical training. The company's core is its proprietary software and hardware for simulating interactions between instruments and anatomy. It has two operating segments; Educational products include Proprietary brand medical simulator hardware and software for generic training of psycho-motor skills, instrument handling, and training for a large number of procedures and examinations, prior to entering the clinical environment and also support and services, and Industry/OEM includes simulation software for product-specific training of surgeons in robot-assisted surgery and other digitalized medical instruments and also simulators for medical device companies.

Surgical Science Sweden AB Headlines

No Headlines